Skip to main content
Top
Published in: Annals of Surgical Oncology 8/2011

01-08-2011 | Bone and Soft Tissue Sarcomas

Retroperitoneal Sarcoma: Is It Time to Change the Surgical Policy?

Authors: Chiara Mussi, MD, Piergiuseppe Colombo, MD, Alexia Bertuzzi, MD, Massimiliano Coladonato, MD, Pietro Bagnoli, MD, Simona Secondino, MD, Pierina Navarria, MD, Emanuela Morenghi, BSc, Armando Santoro, MD, Vittorio Quagliuolo, MD

Published in: Annals of Surgical Oncology | Issue 8/2011

Login to get access

Abstract

Background

Complete tumor resection is the mainstay of treatment for retroperitoneal sarcoma (RPS), but the size and quality of surgical margins for radical resection in RPS are unknown. They are believed to be pushing tumors, but recently, aggressive surgical policies leading to multivisceral resection have seemed to suggest better local control compared with simple tumor resection. We analyzed a single-institution series of RPS to provide information useful to surgical decision-making.

Methods

From 1996 to 2008, 77 patients referred to our institution underwent surgery for primary RPS. Thirty tumors were classified as liposarcoma, and 20 as leiomyosarcoma. Potential prognostic factors were tested retrospectively. Number and pathologic status of resected organs were assessed.

Results

151 organs were resected. Ninety-two were involved by the tumor (60.9%). Liposarcoma involved 48 of 77 organs resected for this histotype (62.3%). Infiltrative pattern was observed in 39/92 organs, and expansive pattern in 53/92 viscera. The infiltrative pattern was more often observed in leiomyosarcoma and non-lipogenic tumors. The expansive pattern was more often observed in liposarcoma. Psoas was the organ most often involved by infiltrative pattern (12/14); the kidney was the organ most often involved by expansive pattern (19/28). 80% of patients had at least one viscera infiltrated by the tumor.

Conclusions

This series, in which an aggressive surgical policy was adopted along with extensive pathologic sampling, shows that RPS has a high rate of viscera infiltration. This growth pattern is characteristic of well-differentiated liposarcoma too. These pathologic data should be considered when planning surgical strategy.
Literature
1.
go back to reference Porter GA, Baxter NN, Pisters PWT. Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery and radiotherapy. Cancer. 2006;106:1610–6.PubMedCrossRef Porter GA, Baxter NN, Pisters PWT. Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery and radiotherapy. Cancer. 2006;106:1610–6.PubMedCrossRef
2.
go back to reference Lewis JJ, Leung D, Woodruff JM, et al. Retroperitoneal soft tissue sarcoma. Analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228(3):355–65.PubMedCrossRef Lewis JJ, Leung D, Woodruff JM, et al. Retroperitoneal soft tissue sarcoma. Analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228(3):355–65.PubMedCrossRef
3.
go back to reference Stoeckle E, Coindre JM, Bonvalot S, et al. Prognostic factors in retroperitoneal sarcoma. A multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer. 2001;92(2):359–68.PubMedCrossRef Stoeckle E, Coindre JM, Bonvalot S, et al. Prognostic factors in retroperitoneal sarcoma. A multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer. 2001;92(2):359–68.PubMedCrossRef
4.
go back to reference Singer S, Corson JM, Demetri GD, et al. Prognostic factors predicting of survival for truncal and retroperitoneal soft tissue sarcoma. Ann Surg. 1995;221(2):185–95.PubMedCrossRef Singer S, Corson JM, Demetri GD, et al. Prognostic factors predicting of survival for truncal and retroperitoneal soft tissue sarcoma. Ann Surg. 1995;221(2):185–95.PubMedCrossRef
5.
go back to reference Mussi C, Collini P, Miceli R, et al. The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution. Cancer. 2008;113:1657–65.PubMedCrossRef Mussi C, Collini P, Miceli R, et al. The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution. Cancer. 2008;113:1657–65.PubMedCrossRef
6.
go back to reference Lahat G, Anaya DA, Wang X, et al. Resectable well-differentiated versus dedifferentiated liposarcomas: two different diseases possibly requiring different treatment approaches. Ann Surg Oncol. 2008;15:1585–93.PubMedCrossRef Lahat G, Anaya DA, Wang X, et al. Resectable well-differentiated versus dedifferentiated liposarcomas: two different diseases possibly requiring different treatment approaches. Ann Surg Oncol. 2008;15:1585–93.PubMedCrossRef
7.
go back to reference Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009;27:24–30.PubMedCrossRef Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009;27:24–30.PubMedCrossRef
8.
go back to reference Pisters PW. Resection of some—but not all—clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcoma. J Clin Oncol. 2009;27:6–8.PubMedCrossRef Pisters PW. Resection of some—but not all—clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcoma. J Clin Oncol. 2009;27:6–8.PubMedCrossRef
9.
go back to reference Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27:31–7.PubMedCrossRef Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27:31–7.PubMedCrossRef
10.
go back to reference Casali PG, Jost L, Sleijfer S, et al. Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008 (Suppl);19:ii89–ii93.PubMedCrossRef Casali PG, Jost L, Sleijfer S, et al. Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008 (Suppl);19:ii89–ii93.PubMedCrossRef
11.
go back to reference Raut CP, Pisters PWT. Retroperitoneal sarcomas; combined-modality treatment approaches. J Surg Oncol. 2006;94:81–7.PubMedCrossRef Raut CP, Pisters PWT. Retroperitoneal sarcomas; combined-modality treatment approaches. J Surg Oncol. 2006;94:81–7.PubMedCrossRef
12.
go back to reference Van Doorn RC, Gallee MPW, Hart AAM, et al. Resectable retroperitoneal soft tissue sarcoma. The effect of extent of resection and post-operative radiation therapy on local tumor control. Cancer. 1994;73(3):637–42.PubMedCrossRef Van Doorn RC, Gallee MPW, Hart AAM, et al. Resectable retroperitoneal soft tissue sarcoma. The effect of extent of resection and post-operative radiation therapy on local tumor control. Cancer. 1994;73(3):637–42.PubMedCrossRef
13.
go back to reference Sindelar WF, Kinsella TJ, Chen PW, et al. Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial. Arch Surg. 1993;128:402–10.PubMed Sindelar WF, Kinsella TJ, Chen PW, et al. Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial. Arch Surg. 1993;128:402–10.PubMed
14.
go back to reference Pisters PW, Ballo MT, Fenstermacher MJ, et al. Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection and intraoperative electron beam radiation therapy for patients with localized retroperitoneal sarcoma. J Clin Oncol. 2003;21:3092–7.PubMedCrossRef Pisters PW, Ballo MT, Fenstermacher MJ, et al. Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection and intraoperative electron beam radiation therapy for patients with localized retroperitoneal sarcoma. J Clin Oncol. 2003;21:3092–7.PubMedCrossRef
15.
go back to reference Robertson JM, Sondak VK, Weiss SA, et al. Preoperative radiation therapy and iododeoxyuridine for large retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys. 1995;31:87–92.PubMedCrossRef Robertson JM, Sondak VK, Weiss SA, et al. Preoperative radiation therapy and iododeoxyuridine for large retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys. 1995;31:87–92.PubMedCrossRef
16.
go back to reference Jones JJ, Catton CN, O’Sullivan B et al. Initial results of a trial of preoperative external beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma. Ann Surg Oncol. 2002;9:346–54.PubMedCrossRef Jones JJ, Catton CN, O’Sullivan B et al. Initial results of a trial of preoperative external beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma. Ann Surg Oncol. 2002;9:346–54.PubMedCrossRef
18.
go back to reference Enneking WP, Spainer SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop. 1980;153:106–20.PubMed Enneking WP, Spainer SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop. 1980;153:106–20.PubMed
19.
go back to reference Brennan M, Alektiar KM, Maki RG. Soft tissue sarcoma. In: DeVita VT, Hellmann S, Rosenberg SA, eds. Cancer. Principles and practice of oncology. Philadelphia: Lippincott Williams & Wilkins; 2001. pp. 1841–91. Brennan M, Alektiar KM, Maki RG. Soft tissue sarcoma. In: DeVita VT, Hellmann S, Rosenberg SA, eds. Cancer. Principles and practice of oncology. Philadelphia: Lippincott Williams & Wilkins; 2001. pp. 1841–91.
20.
go back to reference Gronchi A, Casali PG, Mariani L, et al. Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: a series of patients treated at a single institution. J Clin Oncol. 2005;23:96–104.PubMedCrossRef Gronchi A, Casali PG, Mariani L, et al. Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: a series of patients treated at a single institution. J Clin Oncol. 2005;23:96–104.PubMedCrossRef
21.
go back to reference Bonvalot S, Miceli R, Berselli M, et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centres is safe and is associated with improved local control. Ann Surg Oncol. 2010;17:1507–14.PubMedCrossRef Bonvalot S, Miceli R, Berselli M, et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centres is safe and is associated with improved local control. Ann Surg Oncol. 2010;17:1507–14.PubMedCrossRef
22.
go back to reference Mussi C, Ronellenfitsch U, Jakob J, et al. Post-imatinib surgery in advanced/metastatic GIST: is it worthwhile in all patients? Ann Oncol. 2010;21:403–8.PubMedCrossRef Mussi C, Ronellenfitsch U, Jakob J, et al. Post-imatinib surgery in advanced/metastatic GIST: is it worthwhile in all patients? Ann Oncol. 2010;21:403–8.PubMedCrossRef
Metadata
Title
Retroperitoneal Sarcoma: Is It Time to Change the Surgical Policy?
Authors
Chiara Mussi, MD
Piergiuseppe Colombo, MD
Alexia Bertuzzi, MD
Massimiliano Coladonato, MD
Pietro Bagnoli, MD
Simona Secondino, MD
Pierina Navarria, MD
Emanuela Morenghi, BSc
Armando Santoro, MD
Vittorio Quagliuolo, MD
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 8/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-011-1742-z

Other articles of this Issue 8/2011

Annals of Surgical Oncology 8/2011 Go to the issue